Form 4: MiNK Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Ulf Wiinberg, a Director of MiNK Therapeutics, Inc., received 1,279 shares of common stock on September 1, 2026.
Summary
- Grant/award: acquired 1,279 Common Stock at $10.95 ($14,005) on September 1, 2026; holds 23,929 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ulf Wiinberg — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 1,279 | $11 | $14.0K | 23,929 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (1,279 shares) |
Keywords
insider transaction, Form 4, INKT, MiNK Therapeutics, Inc., neutral, Ulf Wiinberg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.